Antifungal prophylaxis during 7 + 3 induction chemotherapy for acute myeloid leukemia is associated with improved survival, in a setting with low incidence of invasive mold infections-Reference-Cited by-同舟云学术

Antifungal prophylaxis during 7 + 3 induction chemotherapy for acute myeloid leukemia is associated with improved survival, in a setting with low incidence of invasive mold infections

Published:2020-05-21 Issue:2 Volume:29 Page:707-712
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Hsu Andrew^ORCID,Matera Robert,Vieira Kendra,Reagan John L.,Farmakiotis Dimitrios

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

https://link.springer.com/content/pdf/10.1007/s00520-020-05535-5.pdf

Reference19 articles.

1. Halpern AB, Lyman GH, Walsh TJ, Kontoyiannis DP, Walter RB (2015) Primary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia. Blood 126(26):2790–2797. https://doi.org/10.1182/blood-2015-07-627323

2. Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ, Helfgott D, Holowiecki J, Stockelberg D, Goh YT, Petrini M, Hardalo C, Suresh R, Angulo-Gonzalez D (2007) Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 356(4):348–359. https://doi.org/10.1056/NEJMoa061094

3. Lupianez CB, Canet LM, Carvalho A, Alcazar-Fuoli L, Springer J, Lackner M, Segura-Catena J, Comino A, Olmedo C, Rios R, Fernandez-Montoya A, Cuenca-Estrella M, Solano C, Lopez-Nevot MA, Cunha C, Oliveira-Coelho A, Villaescusa T, Fianchi L, Aguado JM, Pagano L, Lopez-Fernandez E, Potenza L, Luppi M, Lass-Florl C, Loeffler J, Einsele H, Vazquez L, Group PS, Jurado M, Sainz J (2015) Polymorphisms in host immunity-modulating genes and risk of invasive aspergillosis: results from the AspBIOmics consortium. Infect Immun 84(3):643–657. https://doi.org/10.1128/IAI.01359-15

4. Network NCC (2020) Prevention and Treatment of Cancer-Related Infections (Version 1.2020). http://www.nccn.org/professionals/physician_gls/pdf/infections.pdf. Accessed Feb 17 2020

5. Maertens JA, Girmenia C, Bruggemann RJ, Duarte RF, Kibbler CC, Ljungman P, Racil Z, Ribaud P, Slavin MA, Cornely OA, Peter Donnelly J, Cordonnier C, European Conference on Infections in Leukaemia ajvotEGfB, Marrow Transplantation tEOfR, Treatment of Cancer tIHSa, European Conference on Infections in Leukaemia ajvotEGfB, Marrow Transplantation tEOfR, Treatment of Cancer tIHS, the European L (2018) European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia. J Antimicrob Chemother 73 (12):3221–3230. https://doi.org/10.1093/jac/dky286

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological Malignancies;Microorganisms;2024-01-06

2. Assessing the impact of prophylactic anidulafungin during remission induction of acute myeloid leukemia – A propensity-score matching analysis;Journal of Medical Mycology;2023-11

3. The impact of antifungal prophylaxis in patients diagnosed with acute leukemias undergoing induction chemotherapy: a systematic review and meta-analysis;Clinical and Experimental Medicine;2023-04-14

4. Improved Outcomes in Acute Myeloid Leukemia Patients Receiving 7+3 Induction By Using Protocolized Antifungal Prophylaxis in a Community Setting;Blood;2022-11-15

5. Updates in infection risk and management in acute leukemia;Hematology;2020-12-04